The clinical study for the mechanism of pioglitazone-induced edema in patients with type 2 diabetes using a salt monitoring system
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000001948
- Lead Sponsor
- Graduate School of Medicine, Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Congestive heart failure or having a history of congestive heart failure 2) Severe ketosis, diabetic coma, or type 1 diabetes 3) Having a severe hepatic or renal dysfunction 4) Having a severe infection or injury, or during perioperative period 5) Having an allergic history of pioglitazone 6) Be pregnant or at risk of becoming pregnant 7) Receiving any diuretic medication 8) Evaluated as being inadequate by the physician-in-charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Onset of edema
- Secondary Outcome Measures
Name Time Method